Excessive gestational weight gain linked with higher cardiovascular risk profile in midlife

Pregnant women with excessive gestational weight gain had a higher cardiovascular risk profile in midlife, according to a new study published in the peer-reviewed Journal of Women's Health.

Franya Hutchins, PhD, from the University of Pittsburgh Graduate School of Public Health, and coauthors used to main measures to determine a woman's cardiovascular disease risk: the atherosclerotic cardiovascular disease (ASCVD) risk score and al measure of the C-reactive protein (CRP), an inflammatory biomarker. The investigators measured these variables at baseline and at 10 follow-up visits, for a total of 20 years of follow-up.

Having a history of excessive gestational weight gain was associated with a 29.6% higher ASCVD risk score at baseline. "In the model including confounders and midlife abdominal obesity, excessive gestational weight gain remained associated with a 9.1% higher ASCVD score," stated the investigators. Excessive gestational weight gain was associated with an 89.2% higher baseline CRP level. With the addition of cofounders and midlife abdominal obesity, excessive gestational weight gain remained associated with a 31.5% higher mean CRP.

In this group of women, a history of excessive gestational weight gain was associated with a small but statistically significant higher ASCVD score and a moderate, statistically significant higher mean CRP level into midlife."

Susan G. Kornstein, MD, Journal of Women's Health Editor-in-Chief, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA

Source:
Journal reference:

Hutchins, F., et al. (2022) Excessive Gestational Weight Gain and Long-Term Maternal Cardiovascular Risk Profile: The Study of Women's Health Across the Nation. Journal of Women's Health. doi.org/10.1089/jwh.2021.0449.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes